|
ErythrocinDrug - Erythrocin The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Erythromycin Lactobionate
Strength -
EQ 500MG BASE/VIAL
Applicant -
ABBOTT
New Drug Application (NDA) Number -
062586
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 4, 1988
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Abbott Laboratories Pharmaceutical Products Div
Erythrocin
Ilotycin Gluceptate Eq 250mg Base/vial Injectable; Injection
Ilotycin Gluceptate Eq 500mg Base/vial Injectable; Injection Erythrocin Eq 1gm Base/vial Injectable; Injection Erythrocin Eq 500mg Base/vial Injectable; Injection Erythromycin Ethylsuccinate Eq 400mg Base Tablet; Oral Erythromycin Ethylsuccinate Eq 400mg Base Tablet; Oral Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl Eq 200mg Base/5ml;eq 600mg Base/5ml Granule; Oral Eryzole Eq 200mg Base/5ml;eq 600mg Base/5ml Granule; Oral Pediazole Eq 200mg Base/5ml;eq 600mg Base/5ml Granule; Oral Ilotycin Gluceptate Eq 1gm Base/vial Injectable; Injection NewDrugInformation |